Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

NYMOX PHARMACEUTICAL CORP (NYMX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Quarterly Report for the Quarter ended June 30, 2023",
"CEO Certifications"
08/02/2023 6-K Quarterly results
07/31/2023 6-K Quarterly results
07/25/2023 6-K Quarterly results
07/25/2023 6-K Quarterly results
07/12/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"For Further Information Contact: Nymox Pharmaceutical Corporation 1-800-93NYMOX www.nymox.com Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of Nymox IRVINE, CA Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] is pleased to announce the appointment of Patrick Doody as Nymox Vice President, General Counsel, and Member of Nymox Board of Directors. Mr. Doody joins Nymox from Pillsbury Winthrop Shaw Pittman LLP, where he was a partner in the Intellectual Property Group, and currently is Senior Counsel. Mr. Doody is a well-respected patent attorney with significant knowledge and experience in post-grant proceedings, patent infringement litigation, patent prosecution, licensing, opinions, and counseling. Mr. Doody has represented Nymox a..."
06/29/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
06/29/2023 6-K/A Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
05/18/2023 4/A Robinson James George (10% Owner) has filed a Form 4 on NYMOX PHARMACEUTICAL CORP
Txns: Bought 40,000 shares @ $0.45, valued at $18k
05/12/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Quarterly Report for the Quarter ended March 31, 2023",
"CEO Certifications",
"CFO Certifications"
05/02/2023 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
03/31/2023 NT 20-F Form NT 20-F - Notification of inability to timely file Form 20-F:
01/06/2023 6-K Quarterly results
11/16/2022 6-K/A Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
11/16/2022 6-K/A Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
11/14/2022 6-K Quarterly results
11/10/2022 6-K Quarterly results
08/15/2022 6-K Quarterly results
07/07/2022 6-K Quarterly results
05/13/2022 6-K Quarterly results
05/06/2022 4 Robinson James George (Director) has filed a Form 4 on NYMOX PHARMACEUTICAL CORP
Txns: Bought 1,151,515 shares @ $1.65, valued at $1.9M
Bought 1,151,515 warrants @ $2, valued at $2.3M
04/13/2022 EFFECT Form EFFECT - Notice of Effectiveness:
03/30/2022 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
03/29/2022 F-3 Form F-3 - Registration statement by foreign private issuers:
03/22/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FROM 6-K",
"Form of Investor Warrant",
"Form of Placement Agent Warrant",
"Opinion of Cutler Law Group, P.C",
"Form of Securities Purchase Agreement, between the Company and the investors party thereto",
"Placement Agent Agreement, between the Company and A.G.P./Alliance Global Partners",
"For Further Information Contact: Nymox Pharmaceutical Corporation 1-800-93NYMOX www.nymox.com Nymox Announces Closing of $6.4 Million Registered Direct Offering"
03/22/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
01/31/2022 EFFECT Form EFFECT - Notice of Effectiveness:
12/09/2021 F-3 Form F-3 - Registration statement by foreign private issuers:
11/22/2021 6-K/A Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
11/19/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Notice of annual general meeting on December 14, 2021",
"Proxy circular",
"Form of proxy",
"Voting instruction form"
11/12/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Quarterly Report for the Quarter ended September 30, 2021",
"CEO Certifications",
"CFO Certifications"
08/13/2021 6-K Quarterly results
06/11/2021 20-F/A Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
05/21/2021 EFFECT Form EFFECT - Notice of Effectiveness:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy